Trial intelligence / Profile preview

Progesterone Supplementation Timing for Day 6 Blastocyst Transfer

NCT04938011Phase 2Unknown

Sponsor
Nanjing University
Start
Jul 2021
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of progesterone in infertility (2 arms), sponsored by Nanjing University. Primary endpoint: Embryo implantation rate at 30 days. Status: unknown.

02

Drugs

progesterone
03

Conditions

infertility

Beyond the preview

Go deeper on NCT04938011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04938011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call